Perfil
William Graham Richards is the founder of Oxford Drug Design Ltd. (founded in 2001) and serves as the Chairman.
Mr. Richards is also the founder of Oxford Molecular Group Plc.
Current job: Advisor at o2h Ltd.
Former jobs: Chairman-Chemistry Department at the University of Oxford (2006), Chairman at OMass Therapeutics Ltd., Non-Executive Director at Oxeco Plc, Non-Executive Director at IP Group Plc (2012-2013), Director at Oxford University Innovation Ltd., Non-Executive Director at Tissue Regenix Group Plc (2006-2010), Director at TdeltaS Ltd., and Non-Executive Director at Crysalin Ltd.
Cargos activos de William Graham Richards
| Empresas | Cargo | Inicio |
|---|---|---|
Oxford Drug Design Ltd.
Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Develops software solutions used for computational methods to discover new leads for drugs | Fundador | 01/01/2001 |
Antiguos cargos conocidos de William Graham Richards.
| Empresas | Cargo | Fin |
|---|---|---|
| IP GROUP PLC | Presidente | 10/09/2009 |
Oxeco Plc
Oxeco Plc Financial ConglomeratesFinance Provides investment services in the technology and science sectors | Director/Miembro de la Junta | 30/06/2010 |
| TISSUE REGENIX GROUP LTD | Director/Miembro de la Junta | 29/06/2010 |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 30/06/2006 |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Consultor / Asesor | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Oxeco Plc
Oxeco Plc Financial ConglomeratesFinance Provides investment services in the technology and science sectors | Finance |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Molecular Group Plc
Oxford Molecular Group Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, chemicals,services in informatics and computation. | Health Technology |
IP Group Plc
IP Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property commercialization and venture capital fund management company | Commercial Services |
Oxford Drug Design Ltd.
Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Develops software solutions used for computational methods to discover new leads for drugs | Technology Services |
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. | Finance |
Tissue Regenix Group Plc
Tissue Regenix Group Plc Medical SpecialtiesHealth Technology Operates as a medical devices company | Health Technology |
TdeltaS Ltd.
TdeltaS Ltd. Miscellaneous Commercial ServicesCommercial Services Provides commercial, physical and biological research and development services | Commercial Services |
Crysalin Ltd.
Crysalin Ltd. BiotechnologyHealth Technology Develops technology for protein structure determination | Health Technology |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform | Commercial Services |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
- Bolsa de valores
- Insiders
- William Graham Richards
















